
NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.
Read More…
Industry, Sector and Symbol
Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
Phone310-883-1300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$89.46 million
Profitability
Miscellaneous
Employees543
Next Earnings Date3/26/2020 (Estimated)
OptionableOptionable
NantHealth (NASDAQ:NH) Frequently Asked Questions
What is NantHealth's stock symbol?
NantHealth trades on the NASDAQ under the ticker symbol "NH."
How were NantHealth's earnings last quarter?
NantHealth Inc (NASDAQ:NH) announced its quarterly earnings results on Thursday, November, 7th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.07) by $0.08. The business earned $22.36 million during the quarter, compared to analyst estimates of $23.40 million. NantHealth had a negative net margin of 105.82% and a negative return on equity of 10,106.10%. View NantHealth's Earnings History.
When is NantHealth's next earnings date?
What price target have analysts set for NH?
1 brokerages have issued 1 year price objectives for NantHealth's shares. Their forecasts range from $1.00 to $1.00. On average, they expect NantHealth's share price to reach $1.00 in the next twelve months. This suggests that the stock has a possible downside of 9.9%. View Analyst Price Targets for NantHealth.
What is the consensus analysts' recommendation for NantHealth?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.
Has NantHealth been receiving favorable news coverage?
News articles about NH stock have been trending somewhat positive on Thursday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. NantHealth earned a news sentiment score of 0.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for NantHealth.
Are investors shorting NantHealth?
NantHealth saw a drop in short interest during the month of October. As of October 15th, there was short interest totalling 723,100 shares, a drop of 6.6% from the September 15th total of 773,900 shares. Based on an average trading volume of 97,400 shares, the short-interest ratio is currently 7.4 days. Currently, 2.2% of the company's stock are sold short. View NantHealth's Current Options Chain.
Who are some of NantHealth's key competitors?
Some companies that are related to NantHealth include ZIX (ZIXI), Sohu.com (SOHU), CooTek (Cayman) (CTK), Brightcove (BCOV), Ooma (OOMA), GTY Technology (GTYH), Castlight Health (CSLT), Fang (SFUN), FRONTEO (FTEO), Park City Group (PCYG), Veritone (VERI), Renren (RENN), Phunware (PHUN), Support.com (SPRT) and Innodata (INOD).
What other stocks do shareholders of NantHealth own?
Who are NantHealth's key executives?
NantHealth's management team includes the folowing people:
- Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)
- Mr. Ronald Allen Louks, COO & Director (Age 54)
- Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)
- Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
- Mr. Charles Hunt, VP of Marketing, Communications & User Experience
When did NantHealth IPO?
(NH) raised $91 million in an initial public offering on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.
Who are NantHealth's major shareholders?
NantHealth's stock is owned by many different of retail and institutional investors. Top institutional investors include Millennium Management LLC (0.15%) and Tower Research Capital LLC TRC (0.04%). View Institutional Ownership Trends for NantHealth.
Which major investors are selling NantHealth stock?
Which major investors are buying NantHealth stock?
How do I buy shares of NantHealth?
Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is NantHealth's stock price today?
One share of NH stock can currently be purchased for approximately $1.11.
How big of a company is NantHealth?
NantHealth has a market capitalization of $122.79 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe.View Additional Information About NantHealth.
What is NantHealth's official website?
How can I contact NantHealth?
NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]
MarketBeat Community Rating for NantHealth (NASDAQ NH)
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.